Geoffrey W Stone

发表

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

A targeted and adjuvanted nanocarrier lowers the effective dose of liposomal amphotericin B and enhances adaptive immunity in murine cutaneous leishmaniasis.

M. Kumar, S. Daunert, E. Dikici, 2013, The Journal of infectious diseases.

Design of vaccine adjuvants incorporating TNF superfamily ligands and TNF superfamily molecular mimics

Sachin Gupta, J. Termini, S. Kanagavelu, 2013, Immunologic Research.

Latent Membrane Protein 1 as a molecular adjuvant for single-cycle lentiviral vaccines

R. Kornbluth, David T. Evans, Sachin Gupta, 2011, Retrovirology.

Mechanism of Action of NB2001 and NB2030, Novel Antibacterial Agents Activated by (cid:2) -Lactamases

N. Georgopapadakou, M. Sergeeva, V. Doppalapudi, 2004 .

A therapeutic HIV-1 vaccine reduces markers of systemic immune activation and latent infection in patients under highly active antiretroviral therapy.

M. Fischl, K. Arheart, M. Fletcher, 2020, Vaccine.

CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals.

M. Ostrowski, Jun Liu, F. Yue, 2008, Vaccine.

Nanoparticle-Delivered Multimeric Soluble CD40L DNA Combined with Toll-Like Receptor Agonists as a Treatment for Melanoma

Daniel G. Anderson, R. Langer, R. Kornbluth, 2009, PloS one.

Epstein Barr virus Latent Membrane Protein-1 enhances dendritic cell therapy lymph node migration, activation, and IL-12 secretion

M. Fischl, Sachin Gupta, J. Termini, 2017, PloS one.

DNA Vaccine Molecular Adjuvants SP-D-BAFF and SP-D-APRIL Enhance Anti-gp120 Immune Response and Increase HIV-1 Neutralizing Antibody Titers

D. Montefiori, Justin C. Boucher, E. Clark, 2015, Journal of Virology.

Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy

M. Fischl, M. Stevenson, S. Pallikkuth, 2015, Journal of Virology.

Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors

B. Issac, Sachin Gupta, J. Termini, 2016, PloS one.

Immunostimulatory combinations: designing the next generation of vaccine adjuvants

R. Kornbluth, Richard S. Kornbluth, Geoffrey W. Stone, 2006, Journal of leukocyte biology.

Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes.

J. Mullins, M. Fischl, G. Pavlakis, 2011, Vaccine.

HIV-1 Adenoviral Vector Vaccines Expressing Multi-Trimeric BAFF and 4-1BBL Enhance T Cell Mediated Anti-Viral Immunity

R. Kornbluth, Sachin Gupta, J. Termini, 2014, PloS one.

Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine.

R. Kornbluth, W. Khan, Jacqueline A. Wright, 2012, Vaccine.

Macaque Multimeric Soluble CD40 Ligand and GITR Ligand Constructs Are Immunostimulatory Molecules In Vitro

J. Lifson, C. Spina, R. Kornbluth, 2006, Clinical and Vaccine Immunology.

Multimeric Soluble CD40 Ligand and GITR Ligand as Adjuvants for Human Immunodeficiency Virus DNA Vaccines

C. Spina, R. Kornbluth, Xiao-Fang Yu, 2006, Journal of Virology.

A multi-trimeric fusion of CD40L and gp100 tumor antigen activates dendritic cells and enhances survival in a B16-F10 melanoma DNA vaccine model.

V. Bhat, A. Farooq, Miguel Otero, 2015, Vaccine.

Design of CD40 Agonists and Their Use in Growing B Cells for Cancer Immunotherapy

R. Kornbluth, M. Stempniak, G. Stone, 2012, International reviews of immunology.

Design of vaccine adjuvants incorporating TNF superfamily ligands and TNF superfamily molecular mimics

Sachin Gupta, J. Termini, S. Kanagavelu, 2013, Immunologic Research.

Regression of Established AB1 Murine Mesothelioma Induced by Peritumoral Injections of CpG Oligodeoxynucleotide Either Alone or in Combination with Poly(I:C) and CD40 Ligand Plasmid DNA

R. Kornbluth, G. Stone, B. Tran, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

EBV LMP1, a viral mimic of CD40, activates dendritic cells and functions as a molecular adjuvant when incorporated into an HIV vaccine

R. Kornbluth, H. Schmidtmayerova, Sachin Gupta, 2011, Journal of leukocyte biology.

Vaccination with a Fusion Protein That Introduces HIV-1 Gag Antigen into a Multitrimer CD40L Construct Results in Enhanced CD8+ T Cell Responses and Protection from Viral Challenge by Vaccinia-Gag

R. Kornbluth, Sachin Gupta, J. Termini, 2013, Journal of Virology.

HIV and HCV augments inflammatory responses through increased TREM-1 expression and signaling in Kupffer and Myeloid cells

D. Dykxhoorn, M. Stevenson, E. Thomas, 2019, PLoS pathogens.

Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands

K. Überla, R. Kornbluth, G. Nchinda, 2009, BMC Immunology.

The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.

M. Ostrowski, Jun Liu, F. Yue, 2009, Vaccine.

Induction and Potential Reversal of a T Cell Exhaustion-Like State: In Vitro Potency Assay for Functional Screening of Immune Checkpoint Drug Candidates

P. Serafini, P. Daftarian, G. Stone, 2020 .

A Targeted and Adjuvanted Nanoparticle for Immunochemotherapy of Leishmania Infections

P. Daftarian, A. Ager, Geoffrey W Stone, 2014, Current Tropical Medicine Reports.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.